Experts suggest that generative AI models in medicine should be licensed similarly to doctors and nurses to ensure accountability and safety.
Key Details
- 1Academic, policy, and public health leaders propose a licensure framework for medical GenAI models, similar to those for clinicians.
- 2UPenn's Eric Bressman and collaborators published a JAMA Internal Medicine opinion highlighting this approach.
- 3A blog post by UPenn policy expert Julia Hinkley supports a federal digital licensing board overseeing medical AI.
- 4FDA could handle premarket review, while state boards might provide ongoing oversight and coordinate standards.
- 5The initiative aims to address concerns about AI hallucinations, performance drift, and maintain standards and accountability.
Why It Matters
As generative AI’s use grows in radiology and other areas, robust and harmonized regulation is critical to maintain quality, safety, and trust. Introducing a licensing system modeled after medical professions could help set clear expectations and mechanisms for oversight of clinical AI systems.
Source
HealthExec
Related News
•HealthExec
EFF Sues CMS For Transparency on AI-Powered Medicare Prior Authorization
EFF has sued CMS to compel disclosure about the WISeR pilot deploying AI for Medicare prior authorization.
•Radiology Business
AI Diagnostic Tools in Imaging Cited as Top Patient Safety Issue for 2026
ECRI ranks AI diagnostic challenges in imaging as the leading patient safety concern for 2026.
•AuntMinnie
ECR 2026: Radiologists Push for Stronger Evidence and EU Support in Imaging AI
European radiologists at ECR 2026 call for more resources to achieve strong evidence and societal impact for radiology AI, especially under new EU HTA regulation.